Back to Multiple Myeloma

Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

  1. MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb

    ACTIVE NOT RECRUITING → COMPLETED

    Recorded 2026-10-20

    View record
  2. Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM

    RECRUITING → UNKNOWN

    Recorded 2026-10-20

    View record
  3. Biomarkers in Multiple Myeloma

    RECRUITING → ACTIVE NOT RECRUITING

    Recorded 2026-10-14

    View record
  4. Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

    RECRUITING → TERMINATED

    Recorded 2026-10-01

    View record